J&J Reports Durable Response in EMD Myeloma With Dual Therapy

Johnson & Johnson reported positive results from a Phase 2 study of the combination of Talvey (talquetamab-tgvs) and Tecvayli (teclistamab-cqyv)—both bispecific antibodies that have been...

Eli Lilly to Acquire Verve Therapeutics in $1.3 Billion Deal

Eli Lilly announced its acquisition of gene-editing startup Verve Therapeutics in a deal with up to a potential of $1.3 billion, expanding its pipeline, which now also features weight-loss medications and its blockbuster diabetes drugs...

Roche's Prasinezumab Heads to Phase III for Early-Stage Parkinson's

Roche has reported it will move prsazinezumab, its investigational anti-alpha-synuclein antibody, into Phase III development for early-stage Parkinson’s disease following an assessment

FQPL Pharma Leaders' National Meet Set for June 21

The Forum for Quality Pharma Leaders (FQPL), will hold its national meeting on June 21 at the JSS College of Pharmacy at JSS Academy of Higher Education and Research (JSSAHER)...

Gujarat to Host Global Pharma Delegation on June 18 in Ahmedabad

Gujarat will soon be able to share its strong pharmaceutical and healthcare ecosystem with the world through an international delegation from 41 countries on June 18, 2025. The visit is part of the 2nd...

EEG-Guided Anesthesia Cuts PAED, Speeds Recovery in Children

Masimo, a global medical technology company developing and producing a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions, announced the find

NVIDIA and Novo Nordisk Join Forces to Accelerate AI-Driven Drug Discovery

NVIDIA has announced a strategic alliance with Novo Nordisk to accelerate drug discovery using the power of AI and supercomputing. The partnership with DCAI's Gefion AI supercomputer, which is...

FDA Approves Enflonsia to Prevent RSV in Infants with One Dose

Merck reported that the USFDA had approved enflosina (clesrovimab-cfor) to prevent respiratory syncytial virus (RSV)-induced lower respiratory tract illness in newborns and babies beginning their first RSV season.

IPA Flags Concern Over MR Ban in Govt Hospitals

The Indian Pharmaceutical Alliance (IPA) represents major domestic drug companies has expressed concern over a recent directive from the government which bans medical representatives from visiting

Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound

Navjot Singh, Executive Director at Trivitron Healthcare, specializes in medical imaging and healthcare technology. With over two decades of expertise in radiography and ultrasound, he drives innovation and sales. Skilled in leadership, he’s earned a

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring